Interferon-Alpha 2-a and Its Dual Effect in Treating Two Diseases (Hepatitis C and Polycythemia Vera)
Hepatitis C and polycythemia vera (PV) co-existence is not rare; it has been reported in the literature. Treatment with interferon (IFN) has been used to treat both conditions; however, the use of IFN in concomitant hepatitis C infection with PV and its outcome are rarely described in the literature...
Main Authors: | Hawraa Shwaylia, Elrazi Ali, Mohamed A. Yassin |
---|---|
Format: | Article |
Language: | English |
Published: |
Karger Publishers
2021-06-01
|
Series: | Case Reports in Oncology |
Subjects: | |
Online Access: | https://www.karger.com/Article/FullText/515782 |
Similar Items
-
Complete hematological and major molecular response through treatment with low‐dose Interferon alpha 2a in high‐risk polycythemia vera patient: a case report
by: Christoph Driessen, et al.
Published: (2021-10-01) -
Can pegylated interferon improve the outcome of polycythemia vera patients?
by: Elena Crisà, et al.
Published: (2017-01-01) -
New Perspectives on Polycythemia Vera: From Diagnosis to Therapy
by: Alessandra Iurlo, et al.
Published: (2020-08-01) -
Polycythemia vera: Perioperative anesthetic challenges and review of literature
by: Suman Saini, et al.
Published: (2019-01-01) -
When hemolysis masks polycythemia vera
by: Coralie Derrieux, et al.
Published: (2019-03-01)